- Disruption of cTnT-Mediated Sarcomere–Mitochondrial Communication Results in Dilated Cardiomyopathy
- From Passive to Proactive: A Call to Action on Valve Disease Screening
- Blood Pressure Lowering Effects of a Novel Long-Acting NPR1 Agonist, XXB750, in Healthy Participants: A Randomized, First-in-Human Clinical Study
- Response by Kristensen et al to Letter Regarding Article, “Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans”
- Letter by Luo et al Regarding Article, “Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans”
- Non-Randomized Database Analyses to Complement Randomized Clinical Trials: Promising Approaches for Cardiovascular Medicine
- Electrical Alternance in a Patient With Type 1 Myotonic Dystrophy: What Diagnosis?
- Genotype-Specific Outcomes of Desmosomal Cardiomyopathies
- Proteomic Signatures for Risk Prediction of Atrial Fibrillation
- Intracellular L-PGDS–Derived 15d-PGJ2 Inhibits CaMKII Through Lipoxidation to Alleviate Cardiac Ischemia/Reperfusion Injury
- Efficacy and Safety of Inclisiran in Adolescents With Genetically Confirmed Homozygous Familial Hypercholesterolemia: Results From the Double-Blind, Placebo-Controlled Part of the ORION-13 Randomized Trial
- Leveraging Transcriptional Readouts as a Platform for Drug Repurposing in Cardiomyopathy
- Response by Bulluck and Hausenloy to Letter Regarding Article, “Effect of Cangrelor on Infarct Size in ST-Segment–Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (the PITRI Trial)”
- Diagnostic Yield and Outcomes of Incidental Thoracic Aortic Dilatation in the National Health Service Targeted Lung Health Check Program: Novel Insights from a Regional Tertiary Center in the United Kingdom
- Factor XI Inhibition for Atrial Fibrillation: Where Do We Stand?
Esprimi il gradimento a questo contenuto
[Totale voti: 0 Media: 0]
